Leaderboards/immunotherapy and immune responses

immunotherapy and immune responses

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Divij Mathew
Parker Institute for Cancer Immunotherapy
99
2
Andy J. Minn
Cancer Research Institute
90
3
Kevin M. Tharp
University of California, San Francisco
80
4
John R. Teijaro
Scripps Research Institute
50
5
Xiaowen Liu
Shanghai Medical College of Fudan University
30
6
Jackie E. Bader
Vanderbilt University Medical Center
20
7
Jeffrey C. Rathmell
Vanderbilt University
10

Rising Stars Papers

1
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Nature|2024
139 cit.
2
Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation
Science Immunology|2024
29 cit.
3
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis
Journal of Clinical Investigation|2024
18 cit.
4
ISG15 Drives Immune Pathology and Respiratory Failure during Systemic Lymphocytic Choriomeningitis Virus Infection
The Journal of Immunology|2024
2 cit.
5
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis
bioRxiv (Cold Spring Harbor Laboratory)|2025
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Qing Guo
Shanghai Medical College of Fudan University
99
2
Guang Lei
The University of Texas MD Anderson Cancer Center
90
3
Shukui Qin
Nanjing University of Chinese Medicine
70
4
Jaroslav Žák
Scripps Research Institute
60
5
Jonathan Chen
Broad Institute
60
6
Yan Mei
Guangdong Academy of Medical Sciences
50
7
Melissa Ng
Agency for Science, Technology and Research
40
8
Junquan Song
Shanghai Medical College of Fudan University
40
9
Shubham Pant
The University of Texas MD Anderson Cancer Center
20

Emerging Leaders Papers

1
NF-κB in biology and targeted therapy: new insights and translational implications
Signal Transduction and Targeted Therapy|2024
1.6k cit.
2
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in <i>BRCA1</i> -Deficient Cancers
Cancer Discovery|2024
45 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Zlatko Trajanoski
Innsbruck Medical University
99
2
Thomas Powles
Queen Mary University of London
90
3
Evangelos J. Giamarellos‐Bourboulis
National and Kapodistrian University of Athens
80
4
Laurence Zitvogel
Université Paris-Sud
80
5
Valerie M. Weaver
University of California, San Francisco
70
6
X. Shirley Liu
Harvard University
70
7
Jennifer A. Wargo
The University of Texas MD Anderson Cancer Center
60
8
Stephen J. Elledge
Brigham and Women's Hospital
50
9
Robert M. Prins
University of California, Los Angeles
40
10
Raúl Rabadán
Columbia University Irving Medical Center
30

All-Time Leaders Papers

1
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Science|2017
4.6k cit.
2
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Genome biology|2016
2.8k cit.
3
B cells and tertiary lymphoid structures promote immunotherapy response
Nature|2020
2.6k cit.
4
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Cell Host & Microbe|2020
2.3k cit.
5
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Genome Medicine|2019
1.7k cit.
6
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
Clinical Cancer Research|2013
936 cit.
7
Mechanics, malignancy, and metastasis: The force journey of a tumor cell
Cancer and Metastasis Reviews|2009
924 cit.
8
CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
The Journal of Experimental Medicine|2005
918 cit.
9
Cistrome: an integrative platform for transcriptional regulation studies
Genome biology|2011
787 cit.
10
Sequence determinants of improved CRISPR sgRNA design
Genome Research|2015
683 cit.

Reagents for immunotherapy and immune responses

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Thermo Fisher Scientific

CD64 Monoclonal Antibody (10.1), PE

Cited in 38 papers
#CD6404-4
View Evidence →Thermo Fisher Scientific

CD61 Monoclonal Antibody (F11), PE

Cited in 38 papers
#CD6104-4
View Evidence →Thermo Fisher Scientific

CD28 Monoclonal Antibody (10F3)

Cited in 38 papers
#CD2800-4
View Evidence →

🌟 All-Time

Most validated

Thermo Fisher Scientific

IL-4 Monoclonal Antibody (E10022)

Cited in 42 papers
#M2IL4I
View Evidence →Thermo Fisher Scientific

IL-4 Monoclonal Antibody (E10022), Biotin

Cited in 42 papers
#M2IL4BI
View Evidence →Cell Signaling Technology

FAM96B (D4V9Z) Rabbit Monoclonal Antibody

Cited in 39 papers
#86302$161
View Evidence →